Careside to launch point-of-care analyser
This article was originally published in Clinica
Executive Summary
US company Careside is on schedule for a year-end launch of a point-of-care blood analyser for a wide range of routine tests, now that it has gained FDA clearance for the device. The device is already cleared for professional laboratory use, but the new clearance opens the potential market to doctors' offices and health clinics. The company's shares increased 12.5% to $6.75 on the day of the news.